Turk Kardiyol Dern Ars. 2005; 33(6): 348-353

Avrupa’da primer perkütan koroner girişimin miyokard infarktüsünde ana reperfüzyon stratejisi olarak gelişimi

Petr Widimsky¹, Michael Aschermann¹, Frantisek Tousek^2
1
2

Randomized trials have confirmed the superiority of primary percutaneous coronary intervention (p-PCI) over thrombolysis as the reperfusion therapy for ST-elevation myocardial infarction. The Czech Republic, where two of these trials were performed, developed a network of PCI centers and satellite hospitals throughout the country, enabling 93% of the reperfusion therapy to be p-PCI in 2003, with thrombolysis accounting for only 7%. In other European countries, however, the p-PCI-to-thrombolysis ratio largely varies between 80:20 and 1:99. In this article, the infrastructure and logistics of the achievement in the Czech Republic are described.

Keywords: Angioplasty, transluminal, percutaneous coronary; Europe; Czech Republic; myocardial infarction/drug therapy; myocardial revascularization; patient transfer; thrombolytic therapy

---

CITE